Evidence map›Paper›PMID 18249095›Full record

ArticleCellular signalling2008

Role of chimaerins, a group of Rac-specific GTPase activating proteins, in T-cell receptor signaling.

María José Caloca, Pilar Delgado, Balbino Alarcón, Xosé R Bustelo

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Diacylglycerol Kinases in T Cell Tolerance and Effector Function.Frontiers in cell and developmental biology · 2016
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Lipid signaling in T-cell development and function.Cold Spring Harbor perspectives in biology · 2010
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

María José CalocaCentro de Investigación del Cáncer and Instituto de Biología Molecular y Celular del Cáncer, CSIC-University of Salamanca, Campus Unamuno, E-37007 Salamanca, Spain. xbustelo@usal.es
Pilar Delgado
Balbino Alarcón
Xosé R Bustelo
Centro de Investigación del Cáncer · ESCentro de Biología Molecular Severo Ochoa · ESUniversidad Autónoma de Madrid · ES

Funding

VAV FAMILY PROTEINS IN CELL SIGNALING AND CANCERR01CA073735 · NCI · UNIVERSITY OF SALAMANCA · PI BUSTELO, XOSE R · 1997 to 2009
$1.8M
NCI NIH HHS R01 CA073735
6 · The paper itself

Abstract

Chimaerins are GTPase-activating proteins that inactivate the GTP-hydrolase Rac1 in a diacylglycerol-dependent manner. To date, the study of chimaerins has been done mostly in neuronal cells. Here, we show that alpha2- and beta2-chimaerin are expressed at different levels in T-cells and that they participate in T-cell receptor signaling. In agreement with this, we have observed that alpha2- and beta2-chimaerins translocate to the T-cell/B-cell immune synapse and, using both gain- and loss-of-function approaches, demonstrated that their catalytic activity is important for the inhibition of the T-cell receptor- and Vav1-dependent stimulation of the transcriptional factor NF-AT. Mutagenesis-based approaches have revealed the molecular determinants that contribute to the biological program of chimaerins during T-cell responses. Unexpectedly, we have found that the translocation of chimaerins to the T-cell/B-cell immune synapse does not rely on the canonical binding of diacylglycerol to the C1 region of these GTPase-activating proteins. Taken together, these results identify chimaerins as candidates for the downmodulation of Rac1 in T-lymphocytes and, in addition, uncover a novel regulatory mechanism that mediates their activation in T-cells.

Indexed as

Signal TransductionB-LymphocytesCD3 ComplexCell MembraneChimerin 1Chimerin ProteinsDiglyceridesDown-RegulationEnzyme ActivationHumansJurkat CellsMutationNeoplasm ProteinsNFATC Transcription FactorsProtein Structure, TertiaryProtein Transportbeta-chimaerinCD3 ComplexChimerin 1Chimerin ProteinsDiglyceridesNeoplasm ProteinsNFATC Transcription FactorsProto-Oncogene Proteins c-vavrac1 GTP-Binding ProteinRAC1 protein, humanReceptors, Antigen, T-CellRecombinant Fusion ProteinsRNA, MessengerRNA, Small InterferingVAV1 protein, human

Identifiers

PMID18249095
PMCPMC2277368
OpenAlexW2022843155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.